Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hannah Baber"'
Autor:
Thorsten Barnhofer, Barnaby D. Dunn, Clara Strauss, Florian Ruths, Barbara Barrett, Mary Ryan, Asha Ladwa, Frances Stafford, Roberta Fichera, Hannah Baber, Ailis McGuinness, Isabella Metcalfe, Delilah Harding, Sarah Walker, Poushali Ganguli, Shelley Rhodes, Allan Young, Fiona Warren
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-18 (2023)
Abstract Background Major depression represents a pressing challenge for health care. In England, Increasing Access to Psychological Therapies (IAPT) services provide evidence-based psychological therapies in a stepped-care approach to patients with
Externí odkaz:
https://doaj.org/article/6b4e3b5db25848ac8075a899959f6426
Autor:
Thorsten Barnhofer, Barnaby D. Dunn, Clara Strauss, Florian Ruths, Barbara Barrett, Mary Ryan, Asha Ladwa, Frances Stafford, Roberta Fichera, Hannah Baber, Ailis McGuinness, Isabella Metcalfe, Delilah Harding, Sarah Walker, Poushali Ganguli, Shelley Rhodes, Allan Young, Fiona Warren
• Background: Major Depression represents a pressing challenge for health care. In England, Increasing Access to Psychological Therapies (IAPT) services provide evidence-based psychological therapies in a stepped care approach to patients with depr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ea8248744e93cbdb597be77ec558eec
https://doi.org/10.21203/rs.3.rs-2121883/v1
https://doi.org/10.21203/rs.3.rs-2121883/v1
Autor:
Yoav Ben-Shlomo, Beth Howden, Jeremy Horwood, Hannah Baber, Ian B. Malone, Athene Lane, Peter S Blair, Lucy E Selman, Ian B. Wilkinson, Clare Clement, Elizabeth Coulthard, Patrick G. Kehoe, Anthony Peter Passmore, Nick C. Fox, David L. Thomas
Publikováno v:
Kehoe, P, Ben-Shlomo, Y, Howden, B, Lane, J A, Coulthard, L, Blair, P, Horwood, J, Selman, L & Clement, C 2017, ' The Rationale and Design of the Reducing Pathology in Alzheimer’s Disease through Angiotensin TaRgeting (RADAR) Trial ', Journal of Alzheimer's Disease, vol. 61, no. 2, pp. 803-814 . https://doi.org/10.3233/JAD-170101
Background: Anti-hypertensives that modify the renin angiotensin system may reduce Alzheimer’s disease pathology and reduce the rate of disease progression. We report a phase II, two arm, double-blind, placebo-controlled, randomised trial (ISRCTN: